NewsRx

Search our medical news database

Medicare and Medicaid

Bernstein Liebhard LLP Announces That Less Than Four Weeks Remain for Chemed Investors to Make a Motion for Lead Plaintiff

Published in Managed Care Weekly Digest, February 27th, 2012

2012 FEB 27 -- Bernstein Liebhard LLP announced that less than four weeks remain for Chemed Corporation ("Chemed" or the "Company") investors to make a motion for lead plaintiff with the Court.

Several weeks ago, a securities class action was commenced in the United States District Court for the Southern District of Ohio on behalf of purchasers of Chemed (NYSE:CHE) common stock during the period between February 15, 2010 and November 16, 2011 (the "Class Period").

The complaint charges Chemed and certain of its officers and directors with violations of the Securities Exchange Act of 1934. Chemed, through its subsidiaries, provides...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Managed Care Weekly Digest


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook